Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15067)
All Articles published online
|
Publishing Process of This Article
|
Apr 7, 2015 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang G, Chen JH, Qiang Y, Wang DZ, Chen Z. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. World J Gastroenterol 2015; 21(13): 3983-3993 [PMID: 25852285 DOI: 10.3748/wjg.v21.i13.3983] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i13/3983.htm |
| Number | Citing Articles |
| 1 |
Jianbo Zhou, Feng Wan, Li Wang, Cheng Peng, Ruizhen Huang, Fu Peng. STAT4 facilitates PD‐L1 level via IL‐12R/JAK2/STAT3 axis and predicts immunotherapy response in breast cancer. MedComm 2023; 4(6) doi: 10.1002/mco2.464
|
| 2 |
Kelvin Anderson, Nathan Ryan, Greta Volpedo, Sanjay Varikuti, Abhay R. Satoskar, Steve Oghumu. Immune Suppression Mediated by STAT4 Deficiency Promotes Lymphatic Metastasis in HNSCC. Frontiers in Immunology 2020; 10 doi: 10.3389/fimmu.2019.03095
|
| 3 |
Bao Zhang, Xiaocui Nie, Xinxin Miao, Shuo Wang, Jing Li, Shengke Wang. Development and verification of an immune‐related gene pairs prognostic signature in ovarian cancer. Journal of Cellular and Molecular Medicine 2021; 25(6): 2918 doi: 10.1111/jcmm.16327
|
| 4 |
Hao Zhang, Renzheng Liu, Lin Sun, Xiao Hu, Irena Ilic. A Reliable Prognostic Model for HCC Using Histological Grades and the Expression Levels of Related Genes. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/9512774
|
| 5 |
Manuel Gentiluomo, Giulia Peduzzi, Ye Lu, Daniele Campa, Federico Canzian. Genetic polymorphisms in inflammatory genes and pancreatic cancer risk: a two-phase study on more than 14 000 individuals. Mutagenesis 2019; doi: 10.1093/mutage/gez040
|
| 6 |
Yannick Verhoeven, Sam Tilborghs, Julie Jacobs, Jorrit De Waele, Delphine Quatannens, Christophe Deben, Hans Prenen, Patrick Pauwels, Xuan Bich Trinh, An Wouters, Evelien L.J. Smits, Filip Lardon, Peter A. van Dam. The potential and controversy of targeting STAT family members in cancer. Seminars in Cancer Biology 2020; 60: 41 doi: 10.1016/j.semcancer.2019.10.002
|
| 7 |
Hairong Zhu, Jian Wu, Xizhong Shen. Genome-wide association study: new genetic insights into HBV/HCV-related hepatocellular carcinoma genomes. Scandinavian Journal of Gastroenterology 2017; 52(2): 209 doi: 10.1080/00365521.2016.1245778
|
| 8 |
Rioko Migita, Yasutaka Kimoto, Junki Hiura, Yuta Okumura, Takahiko Horiuchi, Syuichi Koarada. A Case of Rapidly Progressing Hepatocellular Carcinoma after Administration of JAK Inhibitors to Treat Rheumatoid Arthritis. Case Reports in Rheumatology 2022; 2022: 1 doi: 10.1155/2022/6852189
|
| 9 |
Justin Jit Hin Tang, Dexter Kai Hao Thng, Jhin Jieh Lim, Tan Boon Toh. JAK/STAT signaling in hepatocellular carcinoma. Hepatic Oncology 2020; 7(1) doi: 10.2217/hep-2020-0001
|
| 10 |
JunJun Jia, Xuelian Zhou, Qingfei Chu. Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer. Molecular and Cellular Biochemistry 2024; doi: 10.1007/s11010-024-04983-5
|
| 11 |
Chenyu Li, Jingyuan Zhao, Bingyu Kang, Shuai Li, Jingya Tang, Deshi Dong, Yanwei Chen. Identification and validation of STAT4 as a prognostic biomarker in acute myeloid leukemia. Bioscience Reports 2024; 44(2) doi: 10.1042/BSR20231720
|
| 12 |
Xuan Zhong, Meihua Luo, Yanmei Wu, Xinfeng Zhou, Xinfa Yu, Li Liu, Sidong Chen. Genetic variants in STAT4 and their interactions with environmental factors for the incidence of hepatocellular carcinoma. Cancer Biomarkers 2021; 32(1): 3 doi: 10.3233/CBM-203162
|
| 13 |
Saisai Li, Bo Sheng, Menghuang Zhao, Qi Shen, Haiyan Zhu, Xueqiong Zhu. The prognostic values of signal transducers activators of transcription family in ovarian cancer. Bioscience Reports 2017; 37(4) doi: 10.1042/BSR20170650
|
| 14 |
Wei Ji, Yuankun Liu, Bin Xu, Jie Mei, Chao Cheng, Yong Xiao, Kun Yang, Weiyi Huang, Jiantong Jiao, Hongyi Liu, Junfei Shao. Bioinformatics Analysis of Expression Profiles and Prognostic Values of the Signal Transducer and Activator of Transcription Family Genes in Glioma. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.625234
|
| 15 |
Cheng Wang, Zheng Qu, Li Chen, Yunhao Pan, Yiqing Tang, Guangfu Hu, Ran Gao, Ruijie Niu, Qiang Liu, Xingyan Gao, Yi Fang. Characterization of Lactate Metabolism Score in Breast and Thyroid Cancers to Assist Immunotherapy via Large-Scale Transcriptomic Data Analysis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.928419
|
| 16 |
Xun Qi, Fahong Li, Yao Zhang, Haoxiang Zhu, Feifei Yang, Xinyan Li, Xuhua Jiang, Liang Chen, Yuxian Huang, Jiming Zhang. STAT4 genetic polymorphism significantly affected HBeAg seroconversion in HBeAg‐positive chronic hepatitis B patients receiving Peginterferon‐α therapy: A prospective cohort study in China. Journal of Medical Virology 2022; 94(9): 4449 doi: 10.1002/jmv.27880
|
| 17 |
Chou Yang, Haitao Chen, Bin Zhou, Jianhua Yin, Guangwen Cao, Jinlin Hou, Deke Jiang. The effects of the interactions of STAT4 rs7574865 with HBV mutations on the risk of hepatocellular carcinoma. Molecular Carcinogenesis 2022; 61(10): 933 doi: 10.1002/mc.23449
|
| 18 |
Nandana Jill, Sannidhi Bhootra, Samiyah Kannanthodi, Geetha Shanmugam, Sudeshna Rakshit, Rohit Rajak, Vidhi Thakkar, Koustav Sarkar. Interplay between signal transducers and activators of transcription (STAT) proteins and cancer: involvement, therapeutic and prognostic perspective. Clinical and Experimental Medicine 2023; 23(8): 4323 doi: 10.1007/s10238-023-01198-8
|
| 19 |
Li Zhang, Kuihua Xu, Chuanmiao Liu, Jiasheng Chen. Meta‐analysis reveals an association between signal transducer and activator of transcription‐4 polymorphism and hepatocellular carcinoma risk. Hepatology Research 2017; 47(4): 303 doi: 10.1111/hepr.12733
|
| 20 |
Moritz Otte, Johanna Stachelscheid, Markus Glaß, Linus Wahnschaffe, Qu Jiang, Waseem Lone, Aleksandr Ianevski, Tero Aittokallio, Javeed Iqbal, Michael Hallek, Stefan Hüttelmaier, Alexandra Schrader, Till Braun, Marco Herling. The miR-141/200c-STAT4 Axis Contributes to Leukemogenesis by Enhancing Cell Proliferation in T-PLL. Cancers 2023; 15(9): 2527 doi: 10.3390/cancers15092527
|
| 21 |
Oliver D. Mrowczynski, Achuthamangalam B. Madhankumar, Jeffrey M. Sundstrom, Yuanjun Zhao, Yuka Imamura Kawasawa, Becky Slagle-Webb, Christine Mau, Russell A. Payne, Elias B. Rizk, Brad E. Zacharia, James R. Connor. Exosomes impact survival to radiation exposure in cell line models of nervous system cancer. Oncotarget 2018; 9(90): 36083 doi: 10.18632/oncotarget.26300
|
| 22 |
Xianlun Yin, Junfeng Ge, Xiurong Ge, Jing Gao, Xinhuan Su, Xiaowei Wang, Qunye Zhang, Zhe Wang. MiR‐363‐5p modulates regulatory T cells through STAT4‐HSPB1‐Notch1 axis and is associated with the immunological abnormality in Graves' disease. Journal of Cellular and Molecular Medicine 2021; 25(19): 9364 doi: 10.1111/jcmm.16876
|
| 23 |
Yu Qiu, Chao Pu, Yanchao Li, Baochuang Qi. Construction of a circRNA-miRNA-mRNA network based on competitive endogenous RNA reveals the function of circRNAs in osteosarcoma. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-1134-1
|
| 24 |
Xianwen Yuan, Xitai Sun, Xiaolei Shi, Chunping Jiang, Decai Yu, Weiwei Zhang, Yitao Ding. USP39 regulates the growth of SMMC-7721 cells via FoxM1. Experimental and Therapeutic Medicine 2017; 13(4): 1506 doi: 10.3892/etm.2017.4115
|
| 25 |
Celina Ebersbach, Alicia-Marie K. Beier, Christian Thomas, Holger H. H. Erb. Impact of STAT Proteins in Tumor Progress and Therapy Resistance in Advanced and Metastasized Prostate Cancer. Cancers 2021; 13(19): 4854 doi: 10.3390/cancers13194854
|
| 26 |
Fayyaz Rasool, Binayak Kumar, Deepu Sharma, Sri Krishna Jayadev Magani. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; : 209 doi: 10.1016/B978-0-323-98807-0.00006-5
|
| 27 |
Wei Wang, Si Liu, Funian Lu, Bin Yang, Xucui Zhuang, Jingjing Yin, Gang Chen, Chaoyang Sun. STAT4, a potential predictor of prognosis, promotes CD8 T‑cell infiltration in ovarian serous carcinoma by inducing CCL5 secretion. Oncology Reports 2023; 50(1) doi: 10.3892/or.2023.8577
|
| 28 |
Ran Wei, Huihui Zhang, Jianzhong Cao, Dailei Qin, Wuguo Deng, Shengping Li. Type 1 T Helper Cell-Based Molecular Subtypes and Signature Are Associated with Clinical Outcome in Pancreatic Ductal Adenocarcinoma. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.839893
|
| 29 |
Alan Ayoub, Chimaobi M. Anugwom, Jhon Prieto, Domingo Balderramo, Javier Diaz Ferrer, Angelo Z. Mattos, Marco Arrese, Enrique Carrera, Zwier M. A. Groothuismink, Jeffrey Oliveira, Andre Boonstra, Jose D. Debes. Assessment of STAT4 Variants and Risk of Hepatocellular Carcinoma in Latin Americans and Europeans. Cancers 2023; 15(18): 4530 doi: 10.3390/cancers15184530
|
| 30 |
Xianbin Kong, Qingbo Li, Dong Wang, Miao Wang, Fan Yang, Jingyan Meng. Mechanism of Qizhen decoction-mediated maturation of DC cells to activate the IL-12/JAK2/STAT4 pathway to sensitise PD-1 inhibitors in the treatment of colorectal cancer. Journal of Ethnopharmacology 2024; 320: 117399 doi: 10.1016/j.jep.2023.117399
|
| 31 |
Xin Cheng, Yu Zhang, Fei Song, Fengliang Song, Cheng Gao, Xiaoliang Liang, Feiran Wang, Zhong Chen. <p>URM1 Promoted Tumor Growth and Suppressed Apoptosis via the JNK Signaling Pathway in Hepatocellular Carcinoma</p>. OncoTargets and Therapy 2020; : 8011 doi: 10.2147/OTT.S258843
|